ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Dispensa Group Plc

Dispensa Group Plc (DISP)

2.55
0.00
(0.00%)
마감 23 1월 1:30AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
2.55
매수가
0.10
매도가
5.00
거래량
0.00
0.00 일간 변동폭 0.00
0.1355 52주 범위 2.55
전일 종가
2.55
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
평균 볼륨(3m)
0.00
재정 규모
-
VWAP
-

DISP 최신 뉴스

Official List Removal - Dispensa Group Plc

Official List 19 March 2024   NOTICE OF REMOVAL OF LISTING FROM THE OFFICIAL LIST 19/03/2024 08:00 REMOVAL Dispensa Group Plc The Financial Conduct Authority ("the FCA") removes the securities...

Dispensa Group PLC Cancellation of Trading

Dispensa Group PLC 19 March 2024       19 March 2024       Dispensa Group plc ("Dispensa" or the "Company")   CANCELLATION OF TRADING FROM THE LONDON STOCK EXCHANGE Further to the...

London Stock Exchange Notice Cancellation - Dispensa Group plc

London Stock Exchange Notice 19 March 2024   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE   19/03/2024 - 08:00   At the request of the company the following...

Dispensa Group PLC Result of Meeting & Update on Last Day of Trading

Dispensa Group PLC 14 March 2024   14 March 2024   Dispensa Group plc ("Dispensa" or the "Company")   RESULT OF GENERAL MEETING OF SHAREHOLDERS AND UPDATE ON LAST DAY OF TRADING At the...

Dispensa Group PLC Publication of Delisting Circular & Notice of GM

Dispensa Group PLC 16 February 2024   16 February 2024   Dispensa Group plc ("Dispensa" or the "Company")  Publication of Delisting Circular & Notice of General Meeting   On 13 February...

IN BRIEF: Dispensa to delist from London after 90% share plunge

C - London-based holding company for portfolio of luxury food brands - Plans to call general meeting to approve delist ...

Dispensa Group PLC Proposed Voluntary Delisting & Change of Auditor

Dispensa Group PLC 13 February 2024   13 February 2024 The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse...

Dispensa Group PLC Interim Results - Replacement

Dispensa Group PLC 11 December 2023 The following amendments have been made to the Dispensa Group plc Second Interim Results announcement released on 30 November 2023 at 2.00pm under RNS No...

EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1002.552.552.5500DE
4002.552.552.5500DE
12002.552.552.5500DE
26002.552.552.5500DE
520.92556.92307692311.6252.550.1355154840.70537777DE
156-1.7-404.254.250.1355173031.20470719DE
260-1.7-404.254.250.1355173031.20470719DE

DISP - Frequently Asked Questions (FAQ)

What is the current Dispensa share price?
The current share price of Dispensa is 2.55p
What is the 1 year trading range for Dispensa share price?
Dispensa has traded in the range of 0.1355p to 2.55p during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M
boarddork boarddork 5 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 6 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 6 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 7 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 8 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 8 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 11 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 12 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 12 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 13 분 전
Whats 305
RNVA
theorysuit theorysuit 14 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 15 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 15 분 전
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 15 분 전
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 16 분 전
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 17 분 전
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 17 분 전
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 17 분 전
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 18 분 전
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

최근 히스토리

Delayed Upgrade Clock